This content is restricted.
Brief
The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to update national risk-based control plans and national randomised surveillance plans. This regulation clarifies the submission of these plans, data by Member States, and minimum sampling frequencies, ensuring consistency with existing regulations. This amendment affects the national control programs for pharmacologically active substances, requiring Member States to specify the species to be sampled and competent authorities responsible for implementation. It also eliminates double reporting and ensures compliance with Annex I's additional provisions on minimum sampling frequencies.
Highlights content goes here...
This content is restricted.
